Judges ScientificPLC - Director/PDMR Shareholding
20 July 2026
Judges Scientific plc
("Judges Scientific" or the "Company")
Director/PDMR Shareholding
Judges Scientific, a group focused on acquiring and developing companies in the scientific instrument sector, has been made aware of the following purchases of ordinary shares in the Group under an automatic dividend reinvestment programme on behalf of Brad Ormsby, Chief Financial Officer, and Ralph Elman, Non-Executive Deputy Chair. Full details of which are set out below:
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Bradley Ormsby and spouse
2
Reason for the notification
a)
Position/status
Chief Financial Officer and spouse
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Judges Scientific plc
b)
LEI
2138004EXWWPTW1JOL31
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares in Judges Scientific plc
GB0032398678
b)
Nature of the transaction
Purchase of shares under a dividend reinvestment programme
c)
Price(s) and volume(s)
Price(s)
Volume(s)
4917.5p
63
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
17/07/26
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ralph Elman
2
Reason for the notification
a)
Position/status
Non-Executive Deputy Chair
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Judges Scientific plc
b)
LEI
2138004EXWWPTW1JOL31
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares in Judges Scientific plc
GB0032398678
b)
Nature of the transaction
Purchase of shares under a dividend reinvestment programme
c)
Price(s) and volume(s)
Price(s)
Volume(s)
4917.5p
122
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
17/07/26
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
- Ends -
For further information please contact:
Judges Scientific plc
Tim Prestidge, CEO
Brad Ormsby, CFO
Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Joint Broker)
Stephane Auton
Harry Davies-Ball
Tel: +44 (0) 20 7408 4090
Panmure Liberum (Joint Broker)
Edward Mansfield
William King
Tel : +44 (0) 20 3100 2222
Investec Bank plc (Joint Broker)
Virginia Bull
Carlton Nelson
Tel: +44 (0) 20 7597 4000
Alma (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Sarah Peters
Tel: +44 (0) 20 3405 0205
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHGIGDRSSDDGLG
